113 related articles for article (PubMed ID: 2519544)
21. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
22. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
Robertson MJ; Roy DC; Stone RM; Ritz J
Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916
[No Abstract] [Full Text] [Related]
23. Application of hypothermia to autologous stem cell purging.
Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
[TBL] [Abstract][Full Text] [Related]
24. Peanut agglutinin purging and magnetic microspheres.
Rhodes EG; Baker PK; Duguid JK; Cawley JC
Prog Clin Biol Res; 1992; 377():139-46. PubMed ID: 1438410
[No Abstract] [Full Text] [Related]
25. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery.
Biggs D; Stadtmauer E; Mangan P; Edelstein M; Powlis W; Buzby G; Magee D; Sachs B; Silberstein L
Prog Clin Biol Res; 1994; 389():9-15. PubMed ID: 7535466
[No Abstract] [Full Text] [Related]
26. [Ex vivo purging for autologous hemopoietic progenitor cell transplantation].
Moriyama Y
Rinsho Byori; 1995 Jul; Suppl 99():54-65. PubMed ID: 7474426
[No Abstract] [Full Text] [Related]
27. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
28. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
Jiang R; Han M; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
30. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
Mizuta S; Kawano A
Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
[No Abstract] [Full Text] [Related]
31. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
[TBL] [Abstract][Full Text] [Related]
32. Effects of ex vivo treatment with methylprednisolone and vincristine on bone marrow lymphohematopoietic cells.
Kapoor N; Keever CA; Leong N; Beck EX
Prog Clin Biol Res; 1992; 377():49-56. PubMed ID: 1438443
[No Abstract] [Full Text] [Related]
33. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
34. [Recent advances in the study of autologous hematopoietic stem cell purging].
Wu SK; Lin C; Song ST
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):65-8. PubMed ID: 15946540
[No Abstract] [Full Text] [Related]
35. Use of gene marking in bone marrow transplantation.
Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
[TBL] [Abstract][Full Text] [Related]
36. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
Schrøder H; Clausen N; Thorling K; Hokland P
Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
[TBL] [Abstract][Full Text] [Related]
37. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.
Prentice HG; Macdonald ID; Hamon MD
Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907
[No Abstract] [Full Text] [Related]
38. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
39. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.
Purdy MH; Shpall EJ
Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586
[No Abstract] [Full Text] [Related]
40. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
